Delivering the Added Dimension in Drug Discovery Services
Vice President – Biology
Saravanakumar (SK) has 20 years of experience in discovery biology & pharmacology. SK has worked at leading drug discovery organizations and has held positions of increasing responsibility. SK has managed discovery collaborations with big pharma and biotech companies across United States, Europe & Asia that has led to candidate compounds for clinical development. Before moving to Jubilant Biosys, SK worked at Albany Molecular Research Inc (AMRI), Singapore as a Director and Head of Discovery Biology & Pharmacology for about four years. Prior to AMRI, he worked as a Associate Director of Pre-clinical Biology at Aurigene, India for about seven years. While at AMRI, Singapore & Aurigene, India, SK led interdisciplinary drug discovery teams and provided leadership for discovery programs spanning multiple therapeutic areas including oncology, metabolic disorders, inflammation, & anti-infectives.
SK obtained his PhD degree in Biotechnology from Anna University, India and pursued his postdoctoral research at Baylor College of Medicine at Houston, Texas, where he worked on gene regulation and cell signaling. He also worked as a research fellow at Institute of Molecular & Cell Biology, ASTAR, Singapore where he conducted independent research on molecular mechanisms of neuronal cell survival and cell death. SK has several high impact peer-reviewed publications to his credit, some of which are cited more than few hundred times. At Jubilant Biosys, SK heads the Discovery Biology group.